CRISPR Therapeutics AG

Scientist II, in vivo Gene Insertion

CRISPR Therapeutics AG$130K — $140K *
Pharmaceuticals & Biotech
Less than 5 years of experience
Job Overview by Ladders

Qualifications

  • 5-7 years experience in gene editing and synthetic immunology in academia or industry
  • Degrees in Biology, Immunology, Genetics, Bioengineering, or related fields
  • Technical expertise in cloning, flow cytometry, and primary T cell culturing
  • Experience managing multiple projects effectively
  • Strong communication and teamwork skills

Responsibilities

  • Design and execute workflows for in vivo gene editing in primary cells
  • Collaborate across teams and with vendors to achieve clinical readiness
  • Assess editing efficiency and iterate gene insertion strategies
  • Design and execute assays to quantify transgene integration
  • Conduct T cell phenotyping using multicolor flow cytometry
  • Analyze data and present findings to varied audiences
  • Organize and maintain critical experimental data, including statistical analysis

Benefits

  • Fully on-site roles due to lab and manufacturing nature
  • Opportunities for career growth within a leading gene editing company
  • Access to cutting-edge research in disease treatment
  • Collaborative team environment focused on innovation
  • Comprehensive support with projects across various disciplines
Full Job Description
Job Description:

Position Summary

We are seeking highly motivated, talented, and independent researchers to grow our diverse, innovation-focused CRISPR-X team that pioneers novel in-vivo gene editing therapies for human disease. As part of CRISPR Therapeutics, a leading gene editing company, the candidate will be focused on working with our team on developing and enabling in vivo gene insertion across multiple tissue and cell types, with the goal of advancing cutting-edge in-vivo gene editing modalities across a range of different disease indications. The successful candidate will be comfortable working with different gene editing systems, possess a strong immunology and/or synthetic immunology background, and is comfortable moving into new areas of biology as needed. The position requires enthusiasm, adaptability, attention to detail, and a desire to create new medicines for patients.

Responsibilities
  • Design and execute workflows of conceive, build, and assess in primary cells
    • Requires extensive hands-on knowledge of molecular biology strategies, including advanced cloning methods, experience in handling various primary cell types (including T cells), familiarity with delivery strategies from transfection to viral transduction to novel targeted LNP (tLNP) approaches.
    • Strong sense of teamwork. Collaborate with various groups within CRISPR Tx and outside vendors to advance projects from both an editing and delivery perspective, with the ultimate goal of clinical readiness.
    • Extensive experience in quantitative biology. Iterate on assessing editing efficiency/gene insertion, impact on cell phenotype/construct expression, and ideation of new strategies.
  • Design and execute ddPCR assays to quantify transgene integration efficiency
  • Design and execute T cell phenotyping assays such as multicolor flow cytometry panels
  • Leverage immunology and/or synthetic immunology background to drive innovative editing, delivery, and expression strategies
  • Work cross-functionally to assess editing outcomes in animal models
  • Analyze and present experimental data to a wide range of audiences
  • Generate, manage, evaluate, and maintain critical data in a highly organized manner, providing statistical analysis and troubleshooting where appropriate


Minimum Qualifications
  • Extensive prior experience with gene editing and synthetic immunology in an academic and/or industry setting, with a track record demonstrating significant contributions.
  • Depending on level, degrees in Biology, Immunology, Genetics, Bioengineering, or related disciplines (level commensurate with experience and achievement):
    • Scientist II - PhD with minimum of 2-5+ years relevant experience; non-PhD with 10-12+ years progressive, relevant experience
  • Excellent technical skills for cloning, flow cytometry, primary T cell culturing, editing assays, and assessment of T cell phenotype and function
  • Experience managing multiple projects and priorities; ability to jump in to help other projects as needed
  • Strong communicator with a demonstrated record of being a highly collaborative team player within and across multiple departments


Preferred Qualifications
  • Knowledge and experience with in vivo delivery modalities such as tLNP, AAV, VLP, and others
  • Knowledge and experience with developing novel editing modalities


Competencies
  • Collaborative - Openness, One Team
  • Undaunted - Fearless, Can-do attitude
  • Results Orientation - Delivering progress toward our mission. Sense of urgency in solving problems.
  • Entrepreneurial Spirit - Proactive. Ownership mindset.


Due to the nature of their work, our manufacturing and lab-based positions are located fully on-site.

Scientist II: Base pay range of $130,000 to $140,000+ bonus, equity and benefits

The range provided is CRISPR Therapeutics' reasonable estimate of the base compensation for this role. The actual amount will be based on job-related and non-discriminatory factors such as experience, training, skills, and abilities.

Pursuant to the San Francisco Fair Chance Ordinance, we will consider for employment qualified applicants with arrest and conviction records.

About CRISPR Therapeutics AG

CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The company develops its products through in-house research programs and partnerships with biopharmaceutical companies and academic researchers. Its lead product candidate is CTX001, an ex vivo CRISPR gene-edited therapy for treating patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce high levels of fetal hemoglobin in red blood cells. The company was formerly known as Inception Genomics AG and changed its name to CRISPR Therapeutics AG in April 2014. CRISPR Therapeutics AG was founded in 2013 and is headquartered in Zug, Switzerland.
Learn more about CRISPR Therapeutics AG
Size
473 employees
Market Cap
$3.3 billion
Industry
Net Income
-$348.8 million
Founded
2013
5 Year Trend
+181.6%
Revenue
$720,000
NASDAQ

Similar Jobs

More Jobs at CRISPR Therapeutics AG

More Pharmaceuticals & Biotech Jobs

Find similar Scientist II, in vivo Gene Insertion jobs: